---
document_datetime: 2024-11-08 10:30:39
document_pages: 7
document_pathfilename: www.ema.europa.eu/en/documents/procedural-steps-after/omidria-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf
document_name: omidria-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf
version: success
processing_time: 4.6655168
conversion_datetime: 2025-12-20 01:52:35.919541
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## Omidria

Procedural steps taken and scientific information after the authorisation

| Application number   | Scope                                                                                                                                | Opinion/ Notification 1 issued on   | Commission Decision Issued 2 / amended on   | Product Information affected 3   | Summary                           |
|----------------------|--------------------------------------------------------------------------------------------------------------------------------------|-------------------------------------|---------------------------------------------|----------------------------------|-----------------------------------|
| PSUSA/10419 /202401  | Periodic Safety Update EU Single assessment - phenylephrine / ketorolac                                                              | 03/10/2024                          | n/a                                         |                                  | PRAC Recommendation - maintenance |
| IB/0027              | B.II.b.3.a - Change in the manufacturing process of the finished or intermediate product - Minor change in the manufacturing process | 22/05/2024                          | n/a                                         |                                  |                                   |

1  Notifications are issued for type I variations and Article 61(3) notifications (unless part of a group including a type II variation or extension application or a worksharing application). Opinions are issued for all other procedures.

2  A Commission decision (CD) is issued for procedures that affect the terms of the marketing authorisation (e.g. summary of product characteristics, annex II, labelling, package leaflet). The CD is issued within two months of the opinion for variations falling under the scope of Article 23.1a(a) of Regulation (EU) No. 712/2012, or within one year for other procedures.

3  SmPC (Summary of Product Characteristics), Annex II, Labelling, PL (Package Leaflet).

<!-- image -->

<!-- image -->

<div style=\"page-break-after: always\"></div>

| IAIN/0028/G   | This was an application for a group of variations. A.7 - Administrative change - Deletion of manufacturing sites B.II.b.2.c.1 - Change to importer, batch release arrangements and quality control testing of the FP - Replacement or addition of a manufacturer responsible for importation and/or batch release - control/testing   | 12/04/2024   | 29/05/2024   | SmPC, Annex II and PL   | Not including batch     |
|---------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|--------------|-------------------------|-------------------------|
| IAIN/0026     | B.II.b.1.a - Replacement or addition of a manufacturing site for the FP - Secondary packaging site                                                                                                                                                                                                                                    | 27/11/2023   | n/a          |                         |                         |
| IAIN/0025     | A.1 - Administrative change - Change in the name and/or address of the MAH                                                                                                                                                                                                                                                            | 24/11/2023   | 29/05/2024   | SmPC, Labelling and PL  |                         |
| IB/0024       | B.II.f.1.b.1 - Stability of FP - Extension of the shelf life of the finished product - As packaged for sale (supported by real time data)                                                                                                                                                                                             | 23/06/2023   | 29/05/2024   | SmPC                    |                         |
|               | This was an application for a group of variations. A.7 - Administrative change - Deletion of manufacturing sites A.7 - Administrative change - Deletion of sites                                                                                                                                                                      | 01/06/2023   | n/a          |                         | IA/0023/G manufacturing |
| T/0022        | Transfer of Marketing Authorisation                                                                                                                                                                                                                                                                                                   | 03/02/2023   | 06/03/2023   | SmPC, Labelling and PL  |                         |

<div style=\"page-break-after: always\"></div>

| PSUSA/10419 /202101   | Periodic Safety Update EU Single assessment - phenylephrine / ketorolac                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     | 02/09/2021   | n/a   | PRAC Recommendation - maintenance   |
|-----------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|-------|-------------------------------------|
| IA/0021               | B.I.a.1.f - Change in the manufacturer of AS or of a starting material/reagent/intermediate for AS - Changes to quality control testing arrangements for the AS -replacement or addition of a site where batch control/testing takes place                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  | 23/08/2021   | n/a   |                                     |
| IB/0020/G             | This was an application for a group of variations. B.III.1.a.5 - Submission of a new/updated or deletion of Ph. Eur. Certificate of Suitability to the relevant Ph. Eur. Monograph - New certificate of a non-sterile AS that is to be used in a sterile medicinal product, where water is used in the last steps of the synthesis and the material is not claimed to be endotoxin free B.III.1.a.2 - Submission of a new/updated or deletion of Ph. Eur. Certificate of Suitability to the relevant Ph. Eur. Monograph - Updated certificate from an already approved manufacturer B.III.1.a.2 - Submission of a new/updated or deletion of Ph. Eur. Certificate of Suitability to the relevant Ph. Eur. Monograph - Updated certificate from an already approved manufacturer B.III.1.a.2 - Submission of a new/updated or deletion of Ph. Eur. Certificate of Suitability to the relevant Ph. Eur. Monograph - Updated certificate from an already approved manufacturer | 25/06/2021   | n/a   |                                     |

<div style=\"page-break-after: always\"></div>

| IAIN/0018           | B.III.1.a.3 - Submission of a new/updated or deletion of Ph. Eur. Certificate of Suitability to the relevant Ph. Eur. Monograph - New certificate from a new manufacturer (replacement or addition)                                        | 18/09/2020   | n/a        |                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|---------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|------------|----------------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| PSUSA/10419 /202001 | Periodic Safety Update EU Single assessment - phenylephrine / ketorolac                                                                                                                                                                    | 03/09/2020   | n/a        |                                  | PRAC Recommendation - maintenance                                                                                                                                                                                                                                                                                                                                                                                                   |
| R/0015              | Renewal of the marketing authorisation.                                                                                                                                                                                                    | 28/05/2020   | 23/07/2020 | SmPC, Annex II, Labelling and PL | Based on the review of data on quality, safety and efficacy, the CHMP considered that the benefit-risk balance of Omidria in the approved indication remains favourable, but recommended that one additional five-year renewal be required based on the following pharmacovigilance grounds: Omidria was has not yet been sold in the EU, no post- marketing data from EU is available and therefore a second renewal is requested. |
| IB/0016             | B.II.f.1.b.1 - Stability of FP - Extension of the shelf life of the finished product - As packaged for sale (supported by real time data)                                                                                                  | 17/02/2020   | 23/07/2020 | SmPC                             |                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| IA/0014             | B.I.a.1.f - Change in the manufacturer of AS or of a starting material/reagent/intermediate for AS - Changes to quality control testing arrangements for the AS -replacement or addition of a site where batch control/testing takes place | 11/12/2019   | n/a        |                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| IA/0013/G           | This was an application for a group of variations. A.4 - Administrative change - Change in the name and/or address of a manufacturer or an ASMF holder                                                                                     | 11/12/2019   | n/a        |                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                     |

<div style=\"page-break-after: always\"></div>

|                     | or supplier of the AS, starting material, reagent or intermediate used in the manufacture of the AS or manufacturer of a novel excipient A.7 - Administrative change - Deletion of manufacturing sites                                                                                                                                                                                       |            |            |                        |                                   |
|---------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|------------------------|-----------------------------------|
| IAIN/0012/G         | This was an application for a group of variations. B.II.b.1.a - Replacement or addition of a manufacturing site for the FP - Secondary packaging site B.II.b.2.c.1 - Change to importer, batch release arrangements and quality control testing of the FP - Replacement or addition of a manufacturer responsible for importation and/or batch release - Not including batch control/testing | 03/12/2019 | 23/07/2020 | Annex II and PL        |                                   |
| PSUSA/10419 /201901 | Periodic Safety Update EU Single assessment - phenylephrine / ketorolac                                                                                                                                                                                                                                                                                                                      | 05/09/2019 | n/a        |                        | PRAC Recommendation - maintenance |
| T/0010              | Transfer of Marketing Authorisation                                                                                                                                                                                                                                                                                                                                                          | 01/03/2019 | 25/03/2019 | SmPC, Labelling and PL |                                   |
| II/0008/G           | This was an application for a group of variations. A.5.b - Administrative change - Change in the name and/or address of a manufacturer/importer of the finished product, including quality control sites (excluding manufacturer for batch release) B.II.b.1.f - Replacement or addition of a manufacturing site for part or all of the                                                      | 07/03/2019 | n/a        |                        |                                   |

<div style=\"page-break-after: always\"></div>

|                     | manufacturing process of the FP - Site where any manufacturing operation(s) take place, except batch release, batch control, and secondary packaging, for sterile medicinal products (including those that are aseptically manufactured) excluding biological/ immunological medicinal products B.II.e.4.c - Change in shape or dimensions of the container or closure (immediate packaging) - Sterile medicinal products B.II.e.7.b - Change in supplier of packaging components or devices (when mentioned in the dossier) - Replacement or addition of a supplier B.II.b.2.a - Change to importer, batch release arrangements and quality control testing of the FP - Replacement/addition of a site where batch control/testing takes place B.II.b.2.a - Change to importer, batch release arrangements and quality control testing of the FP - Replacement/addition of a site where batch control/testing takes place B.II.b.4.a - Change in the batch size (including batch size ranges) of the finished product - Up to 10-fold   |            |     |                                   |
|---------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|-----------------------------------|
| PSUSA/10419 /201807 | Periodic Safety Update EU Single assessment - phenylephrine / ketorolac                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  | 14/02/2019 | n/a | PRAC Recommendation - maintenance |
| PSUSA/10419 /201801 | Periodic Safety Update EU Single assessment - phenylephrine / ketorolac                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  | 06/09/2018 | n/a | PRAC Recommendation - maintenance |
| PSUSA/10419 /201707 | Periodic Safety Update EU Single assessment - phenylephrine / ketorolac                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  | 08/02/2018 | n/a | PRAC Recommendation - maintenance |

<div style=\"page-break-after: always\"></div>

| IB/0006             | B.II.f.1.z - Stability of FP - Change in the shelf-life or storage conditions of the finished product - Other variation   | 31/01/2018   | 07/01/2019   | SmPC   |                                   |
|---------------------|---------------------------------------------------------------------------------------------------------------------------|--------------|--------------|--------|-----------------------------------|
| PSUSA/10419 /201701 | Periodic Safety Update EU Single assessment - phenylephrine / ketorolac                                                   | 01/09/2017   | n/a          |        | PRAC Recommendation - maintenance |
| IB/0003             | B.II.f.1.z - Stability of FP - Change in the shelf-life or storage conditions of the finished product - Other variation   | 09/02/2017   | 18/01/2018   | SmPC   |                                   |
| PSUSA/10419 /201607 | Periodic Safety Update EU Single assessment - phenylephrine / ketorolac                                                   | 09/02/2017   | n/a          |        | PRAC Recommendation - maintenance |
| PSUSA/10419 /201601 | Periodic Safety Update EU Single assessment - phenylephrine / ketorolac                                                   | 02/09/2016   | n/a          |        | PRAC Recommendation - maintenance |